UK businesses can apply for a share of up to £3 million to explore and evaluate the commercial potential of a scientific idea to solve a healthcare challenge.
Programme: Innovate UK
Award: Share of up to £3 million
Opens: 21st Jan 2019
Closes: 3rd Apr 2019
The aim of the Biomedical Catalyst is to support the development of innovative healthcare products, technologies and processes. These can include (but are not limited to):
The aim of this competition is to explore and evaluate the commercial potential of an innovative scientific idea or carry out a technical evaluation through to proof of concept in a model system by:
Your project must focus on the development of a product or process that is an innovative solution to a health and care challenge.
Support is available for any life science sector or discipline, including (but not limited to):
To lead a project or work alone you must:
You can work alone or in partnership with others (SMEs, academics or research organisations).
The lead must claim funding.
To be a collaborator you must:
Your project’s total eligible costs must be between £50,000 and £1 million.
For feasibility studies and industrial research projects, you could get funding for your eligible project costs of:
The research organisations in your consortium can share up to 50% of the total eligible project costs. If your consortium contains more than one research organisation, this maximum will be shared between them.
Your project must start by 1 September 2019 and end by 31 March 2021. It can last between 3 and 18 months.
Innovate UK will not fund projects as part of this competition that: